BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 34272384)

  • 21. Role of glucocorticoid signaling in urothelial tumorigenesis: Inhibition by prednisone presumably through inducing glucocorticoid receptor transrepression.
    Ide H; Inoue S; Mizushima T; Kashiwagi E; Zheng Y; Miyamoto H
    Mol Carcinog; 2019 Dec; 58(12):2297-2305. PubMed ID: 31535408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased glucocorticoid receptor activity and proliferation in metastatic colon cancer.
    Tian D; Tian M; Han G; Li JL
    Sci Rep; 2019 Aug; 9(1):11257. PubMed ID: 31375708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct glucocorticoid receptor transcriptional regulatory surfaces mediate the cytotoxic and cytostatic effects of glucocorticoids.
    Rogatsky I; Hittelman AB; Pearce D; Garabedian MJ
    Mol Cell Biol; 1999 Jul; 19(7):5036-49. PubMed ID: 10373553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and functional analysis of SKA2 interaction with the glucocorticoid receptor.
    Rice L; Waters CE; Eccles J; Garside H; Sommer P; Kay P; Blackhall FH; Zeef L; Telfer B; Stratford I; Clarke R; Singh D; Stevens A; White A; Ray DW
    J Endocrinol; 2008 Sep; 198(3):499-509. PubMed ID: 18583474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.
    Dendoncker K; Timmermans S; Vandewalle J; Eggermont M; Lempiäinen J; Paakinaho V; Van Hamme E; Dewaele S; Vandevyver S; Ballegeer M; Souffriau J; Van Wyngene L; Van Looveren K; Vanderhaeghen T; Beyaert R; De Bosscher K; Palvimo JJ; Van Montagu M; Libert C
    Proc Natl Acad Sci U S A; 2019 Jun; 116(26):12942-12951. PubMed ID: 31182584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic redistribution of GR monomers and dimers mediates transcriptional response to exogenous glucocorticoid in vivo.
    Lim HW; Uhlenhaut NH; Rauch A; Weiner J; Hübner S; Hübner N; Won KJ; Lazar MA; Tuckermann J; Steger DJ
    Genome Res; 2015 Jun; 25(6):836-44. PubMed ID: 25957148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor dependent tumor growth in vivo.
    Ji QS; Mulvihill MJ; Rosenfeld-Franklin M; Cooke A; Feng L; Mak G; O'Connor M; Yao Y; Pirritt C; Buck E; Eyzaguirre A; Arnold LD; Gibson NW; Pachter JA
    Mol Cancer Ther; 2007 Aug; 6(8):2158-67. PubMed ID: 17671083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CDKN1C-mediated growth inhibition by an EZH1/2 dual inhibitor overcomes resistance of mantle cell lymphoma to ibrutinib.
    Kagiyama Y; Fujita S; Shima Y; Yamagata K; Katsumoto T; Nakagawa M; Honma D; Adachi N; Araki K; Kato A; Inaki K; Ono Y; Fukuhara S; Kobayashi Y; Tobinai K; Kitabayashi I
    Cancer Sci; 2021 Jun; 112(6):2314-2324. PubMed ID: 33792119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chromatin immunoprecipitation scanning identifies glucocorticoid receptor binding regions in the proximal promoter of a ubiquitously expressed glucocorticoid target gene in brain.
    van der Laan S; Sarabdjitsingh RA; Van Batenburg MF; Lachize SB; Li H; Dijkmans TF; Vreugdenhil E; de Kloet ER; Meijer OC
    J Neurochem; 2008 Sep; 106(6):2515-23. PubMed ID: 18643788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SUMOylation regulates the chromatin occupancy and anti-proliferative gene programs of glucocorticoid receptor.
    Paakinaho V; Kaikkonen S; Makkonen H; Benes V; Palvimo JJ
    Nucleic Acids Res; 2014 Feb; 42(3):1575-92. PubMed ID: 24194604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CDKN1C/P57 is regulated by the Notch target gene Hes1 and induces senescence in human hepatocellular carcinoma.
    Giovannini C; Gramantieri L; Minguzzi M; Fornari F; Chieco P; Grazi GL; Bolondi L
    Am J Pathol; 2012 Aug; 181(2):413-22. PubMed ID: 22705236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cistrome-based Cooperation between Airway Epithelial Glucocorticoid Receptor and NF-κB Orchestrates Anti-inflammatory Effects.
    Kadiyala V; Sasse SK; Altonsy MO; Berman R; Chu HW; Phang TL; Gerber AN
    J Biol Chem; 2016 Jun; 291(24):12673-12687. PubMed ID: 27076634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CDYL promotes the chemoresistance of small cell lung cancer by regulating H3K27 trimethylation at the CDKN1C promoter.
    Qiu Z; Zhu W; Meng H; Tong L; Li X; Luo P; Yi L; Zhang X; Guo L; Wei T; Zhang J
    Theranostics; 2019; 9(16):4717-4729. PubMed ID: 31367252
    [No Abstract]   [Full Text] [Related]  

  • 34. The Antiasthma Medication Ciclesonide Suppresses Breast Cancer Stem Cells through Inhibition of the Glucocorticoid Receptor Signaling-Dependent YAP Pathway.
    Kim SL; Choi HS; Kim JH; Lee DS
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33352739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a novel GR-ARID1a-P53BP1 protein complex involved in DNA damage repair and cell cycle regulation.
    Stubbs FE; Flynn BP; Rivers CA; Birnie MT; Herman A; Swinstead EE; Baek S; Fang H; Temple J; Carroll JS; Hager GL; Lightman SL; Conway-Campbell BL
    Oncogene; 2022 Dec; 41(50):5347-5360. PubMed ID: 36344675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PI3K inhibitors protect against glucocorticoid-induced skin atrophy.
    Agarwal S; Mirzoeva S; Readhead B; Dudley JT; Budunova I
    EBioMedicine; 2019 Mar; 41():526-537. PubMed ID: 30737086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SIRT1 is a transcriptional enhancer of the glucocorticoid receptor acting independently to its deacetylase activity.
    Suzuki S; Iben JR; Coon SL; Kino T
    Mol Cell Endocrinol; 2018 Feb; 461():178-187. PubMed ID: 28923345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucocorticoid receptor binding to chromatin is selectively controlled by the coregulator Hic-5 and chromatin remodeling enzymes.
    Lee BH; Stallcup MR
    J Biol Chem; 2017 Jun; 292(22):9320-9334. PubMed ID: 28381557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kaiso represses the expression of glucocorticoid receptor via a methylation-dependent mechanism and attenuates the anti-apoptotic activity of glucocorticoids in breast cancer cells.
    Zhou L; Zhong Y; Yang FH; Li ZB; Zhou J; Liu XH; Li M; Hu F
    BMB Rep; 2016 Mar; 49(3):167-72. PubMed ID: 26424557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic glucocorticoid action in embryonic mouse neural stem cells.
    Berry KJ; Chandran U; Mu F; Deochand DK; Lei T; Pagin M; Nicolis SK; Monaghan-Nichols AP; Rogatsky I; DeFranco DB
    Mol Cell Endocrinol; 2023 Mar; 563():111864. PubMed ID: 36690169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.